# Biomarker repurposing: opportunities and challenges in the evolving field of laboratory medicine

**Authors:** Damien Gruson, Nassiba Menghoun, Anne-Catherine Pouleur, Antoni Bayes Genis

PMC · DOI: 10.1515/almed-2024-0158 · Advances in Laboratory Medicine · 2024-12-31

## Full-text entities

- **Genes:** FGF23 (fibroblast growth factor 23) [NCBI Gene 8074] {aka ADHR, FGFN, HFTC2, HPDR2, HYPF, PHPTC}, LGALS3 (galectin 3) [NCBI Gene 3958] {aka CBP35, GAL3, GALBP, GALIG, L31, LGALS2}, NPPB (natriuretic peptide B) [NCBI Gene 4879] {aka BNP, Iso-ANP}, MUC16 (mucin 16, cell surface associated) [NCBI Gene 94025] {aka CA125}
- **Diseases:** malignant pleural mesothelioma (MESH:D000086002), pleural effusions (MESH:D010996), cancer (MESH:D009369), edema (MESH:D004487), epithelial-derived tumors (MESH:D002277), fibrosis (MESH:D005355), inflammation (MESH:D007249), conditions (MESH:D020763), sepsis (MESH:D018805), HF (MESH:D006333), ovarian cancer (MESH:D010051), cardiovascular diseases (MESH:D002318), congestion (MESH:D002311)
- **Chemicals:** N-terminal pro-brain natriuretic peptide (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12107413/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12107413/full.md

---
Source: https://tomesphere.com/paper/PMC12107413